Fintel reports that on February 13, 2025, UBS downgraded their outlook for Novartis AG - Depositary Receipt () (NYSE:NVS) ...

Novartis (NVS) has sealed a $3.1 billion deal to acquire clinical-stage biopharmaceutical company Anthos Therapeutics. The ...

Check the time stamp on this data. Updated AI-Generated Signals for Novartis Ag (NVS) available here: NVS. Type a few symbols ...

For new and old investors, taking full advantage of the stock market and investing with confidence are common goals. Zacks Premium provides lots of different ways to do both. The popular research ...

We recently compiled a list of the 10 Best Foreign Stocks With Dividends For Passive Income. In this article, we are going to ...

Despite the issue, ISRO assured that the NVS-02 navigation satellite was successfully injected into the intended ...

According to the latest update by Isro, the NVS-02 navigation satellite, which was launched on Wednesday (January 29), could not complete its orbit-raising operations after it failed to ignite a fire ...

Novartis (NYSE:NVS – Get Free Report) was upgraded by analysts at StockNews.com from a “buy” rating to a “strong-buy” rating ...

ISRO unable to raise orbit of NVS-02 satellite due to valve malfunction, exploring alternate navigation strategies in ...

We recently published a list of 10 Best Annual Dividend Stocks To Buy Now. In this article, we are going to take a look at ...

The satellite, which is intended to bolster India's navigation capabilities, faced a problem during the 'orbit-raising ...

Isro said on Sunday that the satellite’s systems 'are healthy' and that the satellite is in an elliptical orbit around Earth.